Journal profile · Multiple
VIEW
ISSN 2688-3988 · eISSN 2688-268X · Wiley · Australia
VIEW: CAS Zone 3 · Medicine (2025 upgraded edition); fully open access; APC about USD 3,300; median 94 days to acceptance (83 articles, last 24 months); 1,229 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
VIEW is published by Wiley and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Magnetic confinement fusion research, Aging, Elder Care, and Social Issues and Health, Medicine and Society, together about 30.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
VIEW is a high-quality, interdisciplinary and rapid-publication journal focused on “Biodiagnostics” in the field of biomaterials, from in vitro to in vivo, small to mega, fundamentals to application with the emphasis on the biomaterials used particularly in biotechnology and medicine. VIEW embraces all significant advances in the research of: Drug delivery, Lab-on-a-chip, Microfluidics, Bioimaging, Biomarkers, Omics, Biosensors and bioelectronics, Computational diagnostics, Bioinformatics, and Novel diagnostic devices, etc. VIEW publishes full-length research articles, communications, reviews, mini-reviews, perspectives, case reports, analysis and other editorial content of general interest to the field of biomaterials. VIEW aims to be a premier journal for researchers in both academia and industry, providing a platform for transforming research excellence to innovation. VIEW cordially invites you to submit original research and review articles. All papers will be published online as soon as they are accepted and will be fully citable. Starting from March 1st, 2023, all submissions will be subject to an Article Publication Charges (APC) if accepted and published in the journal. For more information on the fees, please click here. Indexing Information CAS: Chemical Abstracts Service (ACS) COMPENDEX (Elsevier) Directory of Open Access Journals (DOAJ) Emerging Sources Citation Index (Clarivate Analytics) Health & Medical Collection (ProQuest) Health Research Premium Collection (ProQuest) INSPEC (IET) OneFile: Health and Medicine (GALE Cengage) OneFile: Nursing and Allied Health (GALE Cengage) OneFile: Science (GALE Cengage) ProQuest Central (ProQuest) ProQuest Central Basic (Korea) (ProQuest) ProQuest Central Essentials (ProQuest) ProQuest Central Student (ProQuest) SCOPUS (Elsevier) Web of Science (Clarivate Analytics)
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Haibo SongPublisher website
Editorial board by country: 30 in mainland China (about 57%); most named Mainland China 30, United States 8, Singapore 6, South Korea 2, United Kingdom 1 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Magnetic confinement fusion researchPhysics and Astronomy14.8%
- Aging, Elder Care, and Social IssuesHealth Professions7.7%
- Health, Medicine and SocietyHealth Professions7.7%
- Hermeneutics and Narrative IdentityArts and Humanities7.7%
- Particle accelerators and beam dynamicsEngineering7.3%
- Educational and Social StudiesSocial Sciences6.1%
- Fusion materials and technologiesMaterials Science5.6%
- Historical and Environmental StudiesSocial Sciences4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Materials Science, Biomaterials | Zone 3 |
| Minor | Nanoscience & Nanotechnology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Nanoscience & Nanotechnology | Zone 2 |
| Minor | Materials Science, Biomaterials | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
| Minor | Nanoscience & Nanotechnology | Zone 4 |
Top journal: noReview journal: no
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexWeb of ScienceINSPECCASPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 11.7LetPub ·
- SJR 2026-06
- 1.41LetPub ·
- SNIP 2026-06
- 1.14LetPub ·
- h-index
- 70OpenAlex ·
- i10-index
- 641OpenAlex ·
- 2-year mean citedness
- 0.37OpenAlex ·
- Self-citation rate
- 2.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 108LetPub ·
Articles by year OpenAlex count · 29,926 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 151 | 151 | 14 |
| 2025 | 1,229 | 1,229 | 383 |
| 2024 | 1,619 | 1,619 | 700 |
| 2023 | 1,632 | 1,632 | 1,178 |
| 2022 | 1,883 | 1,883 | 1,871 |
| 2021 | 1,817 | 1,815 | 3,074 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 66 days – 136 days
- Acceptance to online
- median 20 days (83 articles)
- Submission to online
- median 124 days
- Sample
- 83 articles with submission and acceptance dates (231 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,300 / GBP 2,420 / EUR 2,860 | Yes | CC BY | |
| OpenAlex | USD 3,000 / EUR 2,600 / GBP 2,200 | — | — | |
| LetPub | USD 3,000 / GBP 2,200 / EUR 2,600 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Cover letter
- Required
Article types accepted5
- editorial(4) Editorial [only by invitation from the Editors] Description: Written by Editorial Board members, invited authors or editors.Length not stated
- letter to the editor and response(6) Letter to the Editor and Response Description: Letters to the Editor must offer perspective on content published in the journal.Length not stated
- mini review(3) Mini Review Description: Mini Reviews are comprehensive analyses of a specific topic.Length not stated
- research article(1) Research Article Description: Research Articles are reports of original studies within the journal’s scope.Length not stated
- review(2) Review Description: Review Articles are comprehensive analyses of a specific topic.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access
- Authorship Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
You will be asked to provide a conflict of interest statement during the submission process. See the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on what to include in this section. Please ensure you liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
Data sharing Model summary
VIEW encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper. Shared data should be cited. All accepted manuscripts may elect to publish a data ava…
Source ↗Publisher website ·- Publication ethics Publication Ethics
Publication ethics Model summary
The journal is committed to high standards for professional conduct and ethical behavior in all published material. The Publication Ethics Guidelines detail the journal's position as a scientific publisher.
Source ↗Publisher website ·- License & copyright
CC BY license Model summary
Accepted papers will be published under CC BY - Creative Commons Attribution License.
Source ↗Publisher website ·- Open access
Open access Model summary
All articles published by VIEW are fully open access where they are immediately freely available to read, download and share.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- Australia
- Language
- English
- ISSN
- 2688-3988
- Electronic ISSN
- 2688-268X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about VIEW
What CAS zone is VIEW in?
In the 2025 upgraded edition of the CAS Journal Ranking, VIEW is in Zone 3 of Medicine, and in Zone 3 of the minor category Materials Science, Biomaterials / Nanoscience & Nanotechnology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at VIEW?
Based on the dates recorded on 83 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 66–136 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of VIEW?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of VIEW based?
Of the 53 board members whose country the journal's board page names, 30 (about 57%) are in mainland China; the countries named most often are Mainland China (30), United States (8) and Singapore (6). Counted from the institutions listed on the board page; for reference only.
Which databases index VIEW?
According to LetPub and DOAJ records, VIEW is indexed in ESCI, Scopus and DOAJ. The journal's website also lists EI Compendex, Web of Science, INSPEC and CAS; that list has not been checked against each database.
Is VIEW open access, and what is the APC?
VIEW is a fully open-access journal. APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .